Psychedelic mushroom extract may offer enhanced brain benefits over synthetic psilocybin

PsyPost, Story by Eric W. Dolan

In recent years, the scientific community has turned its attention back to the potential of psychedelics as therapeutic agents, with psilocybin, a naturally occurring substance found in certain mushrooms, at the forefront of this research. A new study published in the journal Molecular Psychiatry suggests possible benefits of using psilocybin-containing mushroom extract over its chemically synthesized counterpart for the treatment of psychiatric disorders such as depression, PTSD, obsessive-compulsive disorders, and anxiety….

For the entire article, please click HERE.

ABOUT OPTIMI

(CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN)

FOR INTERVIEW REQUESTS OR FURTHER INFORMATION PLEASE CONTACT:

Investor Relations
Email: investors@optimihealth.ca
Phone: +1 (902) 880 6121
Web: www.optimihealth.ca

FOR INTERVIEW REQUESTS OR FURTHER INFORMATION PLEASE CONTACT:

Investor Relations
Email: investors@optimihealth.ca
Phone: +1 (902) 880 6121
Web: www.optimihealth.ca

FORWARD‐LOOKING STATEMENTS

Products do not contain psilocybin

Search
Get news & updates directly to your inbox.
Interested In Optimi? Let's Talk.